The Clinical Efficacy of Different Durations of Suprascapular Nerve Pulsed Radiofrequency
Launched by ANKARA UNIVERSITY · Nov 30, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment for chronic shoulder pain caused by conditions like shoulder impingement syndrome and supraspinatus tendinosis. These conditions can make daily activities difficult and painful. The researchers want to find out if using short bursts of electrical stimulation on the suprascapular nerve, which helps control pain in the shoulder, can provide longer-lasting relief. They will compare two different durations of this stimulation to see which one works better for managing pain.
To participate in this trial, individuals should be between 18 and 80 years old and have been experiencing shoulder pain for at least three months, with a pain level of 4 or higher on a scale of 0 to 10, despite trying other treatments. Participants will receive the nerve stimulation treatment and will be monitored for its effectiveness. It's important to note that individuals with certain medical conditions, like uncontrolled diabetes or a history of shoulder surgery on the affected side, will not be eligible to join the study. This trial aims to help improve pain management strategies for those suffering from chronic shoulder pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18-80 years
- • Shoulder pain caused by impingement syndrome
- • Shoulder pain due to supraspinatus tendinosis
- • Diagnosis of impingement syndrome and supraspinatus tendinosis confirmed through physical examination and radiological imaging (MRI)
- • Pain persisting for 3 months or longer
- • Numeric Pain Rating Scale (NRS) score of 4 or higher despite conservative treatment
- Exclusion Criteria:
- • Patients unwilling to participate in the study
- • Presence of chronic pain due to other conditions
- • Presence of cervical radiculopathy
- • History of opioid use
- • Uncontrolled diabetes (HbA1c \> 8)
- • History of shoulder surgery on the affected side
- • Uncontrolled psychiatric disorders despite medical treatment
- • History of cancer
- • History of stroke
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Güngör Enver Özgencil, Prof Dr
Study Director
Ankara University School of Medicine Department of Anesthesiology and Reanimation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported